Literature DB >> 34859857

The effect of extracorporeal shockwave myocardial revascularization therapy to myocardial perfusion and function in indicated CABG-stable angina pectoris patients: case series.

B B Tiksnadi1, D L Adiputro, M R Akbar, E A Soeriadi, M Hasan, F Muttaqien, P P Raharjo, E Nurazizah, N F Tarsidin.   

Abstract

OBJECTIVE: Many studies have found a beneficial effect of Extracorporeal Shockwave Myocardial Revascularization (ESMR) therapy for refractory angina patients. However, clinical studies ESMR therapy for indicated coronary artery bypass grafting (CABG)-stable angina pectoris (SAP) patients are limited. PATIENTS AND METHODS: Four indicated CABG-SAP patients CCS class I-III reviewed in this study. All patients refuse to CABG procedure. Data of myocardial perfusion and function from medical records were collected.
RESULTS: After ESMR therapy, summed rest score was improved in patient 1 from 14 to 8, Patient 2 from 10 to 5, and Patient 3 from 6 to 4. Summed stress score was improved in patient 1 from 31 to 19. Left ventricular ejection fraction was improved in patient 1 at rest from 59 to 67% and stress from 39 to 57%. The global longitudinal strain was improved in patient 1 from -16 to -20.9 and Patient 3 from -14.8 to -18.2. Diastolic dysfunction severity was improved in patient 2 and patient 3 from grade 2 to grade 1.
CONCLUSIONS: In our case series, ESMR therapy for indicated CABG-SAP patients might improve myocardial perfusion and function, especially for patients with a high ischemic burden.

Entities:  

Mesh:

Year:  2021        PMID: 34859857     DOI: 10.26355/eurrev_202111_27244

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  1 in total

1.  Case Series: Extracorporeal Shockwave Myocardial Revascularization Therapy Improves Ischemic Response, Functional Capacity, and Quality of Life in Indicated CABG-Stable Angina Pectoris Patients.

Authors:  Mohammad Rizki Akbar; Dwi Laksono Adiputro; Badai Bhatara Tiksnadi; Erwin Affandi Soeriadi; Melawati Hasan; Fauzan Muttaqien; Pradana Pratomo Raharjo; Eliza Nurazizah; Najmi Fauzan Tarsidin
Journal:  Front Cardiovasc Med       Date:  2022-02-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.